Your institution may have access to this item. Find your institution then sign in to continue.
Title
A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation.
Authors
Dipalma, Jack A; Cleveland, Mark Vb; McGowan, John; Herrera, Jorge L
Abstract
Polyethylene glycol (PEG) 3350 (MiraLAX) is currently approved for the short-term treatment of occasional constipation. This study was designed to compare the safety and efficacy of PEG laxative versus placebo over a 6-month treatment period in patients with chronic constipation.
Publication
The American journal of gastroenterology, 2007, Vol 102, Issue 7, p1436